Marianne Engelhard

Essen, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms.

Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms.

Journal: Leukemia
Published: June 16, 2023

Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER Trial.

Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER Trial.

Journal: HemaSphere
Published: December 08, 2022

Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study.

Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study.

Journal: HemaSphere
Published: November 29, 2022

Molecular Cytogenetic Profiling Reveals Similarities and Differences Between Localized Nodal and Systemic Follicular Lymphomas.

Molecular Cytogenetic Profiling Reveals Similarities and Differences Between Localized Nodal and Systemic Follicular Lymphomas.

Journal: HemaSphere
Published: March 03, 2022

Localized- and advanced-stage follicular lymphomas differ in their gene expression profiles.

Localized- and advanced-stage follicular lymphomas differ in their gene expression profiles.

Journal: Blood
Published: March 11, 2019

Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial.

Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial.

Journal: Trials
Published: December 07, 2018

Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma: Results of the MIR Study.

Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma: Results of the MIR Study.

Journal: HemaSphere
Published: July 21, 2018

Allogeneic haematopoietic cell transplantation offers the chance of cure for patients with transformed follicular lymphoma.

Allogeneic haematopoietic cell transplantation offers the chance of cure for patients with transformed follicular lymphoma.

Journal: Journal of cancer research and clinical oncology
Published: February 07, 2018

Anti-CD20 antibody treatment of non-Hodgkin lymphomas.

Anti-CD20 antibody treatment of non-Hodgkin lymphomas.

Journal: Clinical immunology (Orlando, Fla.)
Published: July 18, 2016

Long-term follow-up of pediatric patients receiving total body irradiation before hematopoietic stem cell transplantation and post-transplant survival of >2 years.

Long-term follow-up of pediatric patients receiving total body irradiation before hematopoietic stem cell transplantation and post-transplant survival of >2 years.

Journal: Pediatric blood & cancer
Published: October 10, 2012

The composition of the microenvironment in follicular lymphoma is associated with the stage of the disease.

The composition of the microenvironment in follicular lymphoma is associated with the stage of the disease.

Journal: Human pathology
Published: November 10, 2011
Showing 1-11 of 11

Last Updated: 09/26/2026